SELLING SICKNESS: THE PHARMACEUTICAL INDUSTRY AND DISEASE BRANDING | Big Pharma Documentary
FilmIsNow Movies・2 minutes read
A newly discovered illness, Monday morning dysphoric trouble (MMDT), affects one in three adults and can significantly impact one's life. Pharmaceutical companies manipulate disease definitions and medications for profit, leading to ethical concerns and potential risks for patients.
Insights
- MMDT, a newly discovered illness, impacts one in three adults, causing irritability, social withdrawal, and headaches, significantly affecting individuals' lives.
- Pharmaceutical companies engage in "illness shaping," creating fictitious illnesses like metabolic syndrome, pushing medications with severe side effects such as Accomplia, raising ethical concerns about their practices and manipulation of research.
Get key ideas from YouTube videos. It’s free
Recent questions
What is metabolic syndrome?
Metabolic syndrome is a serious condition affecting one in four individuals, characterized by abdominal obesity, diabetes, hypertension, and cholesterol, posing a risk of cardiovascular accidents.
What are the side effects of Accomplia?
Accomplia, a drug marketed as a solution for metabolic syndrome, causes severe side effects, including psychiatric issues and suicides, despite being approved for sale by the European Medicines Agency (EMA) and later banned due to its dangers.
How do pharmaceutical companies manipulate diseases?
Pharmaceutical companies manipulate disease definitions to expand their markets, as seen with diabetes and cholesterol thresholds, creating fictitious illnesses and medications to increase sales, a practice known as "illness shaping."
What is osteoporosis disease mongering?
Osteoporosis is portrayed as a silent killer to drive drug sales, sponsored by pharmaceutical companies like Amgen, blurring lines between education and promotion, leading to overdiagnosis and unnecessary treatments based on a bone density standard of a 30-year-old woman.
What are the ethical concerns regarding pharmaceutical funding?
Dr. Duprey and Dr. Hansel received funding from Sanofi, a pharmaceutical company, for their research on abdominal obesity, raising ethical concerns about accepting money from pharmaceutical companies. Dr. Hansel's ties to Sanofi were questioned when he recommended a medication without disclosing his connections, leading to suspicions of manipulation in the medical field.
Related videos
Psych2Go
6 Most Misunderstood Mental Disorders You Should Know About
Sam Bergmann
Gen Psy Lecture Recording Psychological Disorders Part 1
Chris Williamson
The Raw Truth About The Pursuit Of Greatness - Mike Thurston
khanacademymedicine
Categories of mental disorders | Behavior | MCAT | Khan Academy
TEDx Talks
Improving our neuroplasticity | Dr. Kelly Lambert | TEDxBermuda